XML 25 R7.htm IDEA: XBRL DOCUMENT v3.25.4
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Treasury Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance at Dec. 31, 2022 $ 3,816 $ 1 $ 577 $ (674) $ (388) $ 4,300
Beginning balance (in shares) at Dec. 31, 2022   127,534,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 235         235
Other comprehensive income 89       89  
Common stock repurchase (in shares)   (3,521,000)        
Common stock repurchase (145)     (145)    
Stock-based compensation (in shares)   17,000.000        
Stock-based compensation 60   60      
Stock issued for employee stock purchase plan (in shares)   1,855,000        
Stock issued for employee stock purchase plan 59   59      
Stock issued under stock plans (in shares)   205,000        
Stock issued under stock plans (1)   (1)      
Ending balance at Dec. 31, 2023 4,113 $ 1 695 (819) (299) 4,535
Ending balance (in shares) at Dec. 31, 2023   126,090,000.000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 395         395
Other comprehensive income 60       60  
Common stock repurchase (in shares)   (5,460,000)        
Common stock repurchase (312)     (312)    
Stock-based compensation (in shares)   13,000.000        
Stock-based compensation 52   52      
Stock issued for employee stock purchase plan (in shares)   2,219,000        
Stock issued for employee stock purchase plan 66   66      
Stock issued under stock plans (in shares)   257,000        
Stock issued under stock plans (2)   (2)      
Ending balance at Dec. 31, 2024 $ 4,372 $ 1 811 (1,131) (239) 4,930
Ending balance (in shares) at Dec. 31, 2024 123,119,199 123,119,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 100         100
Other comprehensive income 66       66  
Common stock repurchase (in shares)   (11,254,000)        
Common stock repurchase (570)     (570)    
Stock-based compensation (in shares)   14,000.000        
Stock-based compensation 69   69      
CARES Act warrants exercised   810,000        
Stock issued for employee stock purchase plan (in shares)   1,973,000        
Stock issued for employee stock purchase plan 73   73      
Stock issued under stock plans (in shares)   869,000        
Stock issued under stock plans 8   8      
Ending balance at Dec. 31, 2025 $ 4,118 $ 1 $ 961 $ (1,701) $ (173) $ 5,030
Ending balance (in shares) at Dec. 31, 2025 115,530,889 115,531,000